BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31359391)

  • 21. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
    Lee HY; Dawson MI; Walsh GL; Nesbitt JC; Eckert RL; Fuchs E; Hong WK; Lotan R; Kurie JM
    Cell Growth Differ; 1996 Aug; 7(8):997-1004. PubMed ID: 8853895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
    Defacque H; Sévilla C; Piquemal D; Rochette-Egly C; Marti J; Commes T
    Leukemia; 1997 Feb; 11(2):221-7. PubMed ID: 9009084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors.
    Giner XC; Cotnoir-White D; Mader S; Lévesque D
    FASEB J; 2015 Oct; 29(10):4256-67. PubMed ID: 26148973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating Novel RXR Agonists That Induce ApoE and Tyrosine Hydroxylase in Cultured Human Glioblastoma Cells.
    Mallick S; Marshall PA; Wagner CE; Heck MC; Sabir ZL; Sabir MS; Dussik CM; Grozic A; Kaneko I; Jurutka PW
    ACS Chem Neurosci; 2021 Mar; 12(5):857-871. PubMed ID: 33570383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes.
    Howell SR; Shirley MA; Ulm EH
    Drug Metab Dispos; 1998 Mar; 26(3):234-9. PubMed ID: 9492386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural and Structure-based RXR Ligand Scaffolds and Their Functions.
    Dominguez M; Alvarez S; de Lera AR
    Curr Top Med Chem; 2017; 17(6):631-662. PubMed ID: 27320335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer.
    Moerland JA; Zhang D; Reich LA; Carapellucci S; Lockwood B; Leal AS; Krieger-Burke T; Aleiwi B; Ellsworth E; Liby KT
    Sci Rep; 2020 Dec; 10(1):22244. PubMed ID: 33335263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers.
    Kotani H; Tanabe H; Mizukami H; Amagaya S; Inoue M
    Biol Pharm Bull; 2012; 35(1):1-9. PubMed ID: 22223330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors.
    Sanchez PV; Glantz ST; Scotland S; Kasner MT; Carroll M
    Leukemia; 2014 Apr; 28(4):749-60. PubMed ID: 23823656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of differential secondary effects of novel rexinoids: select rexinoid X receptor ligands demonstrate differentiated side effect profiles.
    Marshall PA; Jurutka PW; Wagner CE; van der Vaart A; Kaneko I; Chavez PI; Ma N; Bhogal JS; Shahani P; Swierski JC; MacNeill M
    Pharmacol Res Perspect; 2015 Mar; 3(2):e00122. PubMed ID: 26038698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral retinoids and rexinoids in cutaneous T-cell lymphomas.
    Sokołowska-Wojdyło M; Lugowska-Umer H; Maciejewska-Radomska A
    Postepy Dermatol Alergol; 2013 Feb; 30(1):19-29. PubMed ID: 24278042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells.
    Benoit GR; Flexor M; Besançon F; Altucci L; Rossin A; Hillion J; Balajthy Z; Legres L; Ségal-Bendirdjian E; Gronemeyer H; Lanotte M
    Mol Endocrinol; 2001 Jul; 15(7):1154-69. PubMed ID: 11435615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arrays.
    Kim HT; Kong G; Denardo D; Li Y; Uray I; Pal S; Mohsin S; Hilsenbeck SG; Bissonnette R; Lamph WW; Johnson K; Brown PH
    Cancer Res; 2006 Dec; 66(24):12009-18. PubMed ID: 17178900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional modulations by RXR agonists are only partially subordinated to PPARalpha signaling and attest additional, organ-specific, molecular cross-talks.
    Martin PG; Lasserre F; Calleja C; Van Es A; Roulet A; Concordet D; Cantiello M; Barnouin R; Gauthier B; Pineau T
    Gene Expr; 2005; 12(3):177-92. PubMed ID: 16128002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The retinoid X receptor has a critical role in synthetic rexinoid-induced increase in cellular all-trans-retinoic acid.
    Belyaeva OV; Klyuyeva AV; Vyas A; Berger WK; Halasz L; Yu J; Atigadda VR; Slay A; Goggans KR; Renfrow MB; Kane MA; Nagy L; Kedishvili NY
    PLoS One; 2024; 19(4):e0301447. PubMed ID: 38557762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics.
    Hanish BJ; Hackney Price JF; Kaneko I; Ma N; van der Vaart A; Wagner CE; Jurutka PW; Marshall PA
    Steroids; 2018 Jul; 135():36-49. PubMed ID: 29704526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice.
    Li Y; Zhang Y; Hill J; Kim HT; Shen Q; Bissonnette RP; Lamph WW; Brown PH
    Br J Cancer; 2008 Apr; 98(8):1380-8. PubMed ID: 18362934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamics-Based Strategy of Using Retinoic Acid Receptor and Retinoid X Receptor Agonists to Induce MicroRNA-10a and Inhibit Atherosclerotic Lesion.
    Lee DY; Chiu JJ
    Methods Mol Biol; 2019; 2019():143-169. PubMed ID: 31359395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3H-Imidazo[4,5-b]pyridine-6-carboxylic acid derivatives as rexinoids with reduced teratogenicity.
    Takamura Y; Takahashi M; Nishii M; Shibahara O; Watanabe M; Fujihara M; Kakuta H
    Bioorg Med Chem Lett; 2019 Aug; 29(15):1891-1894. PubMed ID: 31160175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
    Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
    Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.